Community Research and Development Information Service - CORDIS

H2020

MIROCALS

Project reference: 633413
Funded under

Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients

From 2015-09-01 to 2019-08-31, ongoing project

Project details

Total cost:

EUR 6 510 742,7

EU contribution:

EUR 5 980 435

Coordinated in:

France

Call for proposal:

H2020-PHC-2014-two-stageSee other projects for this call

Funding scheme:

RIA - Research and Innovation action

Objective

Related information

Open Access

Coordinator

CENTRE HOSPITALIER UNIVERSITAIRE
France

EU contribution: EUR 1 646 473


PLACE DU PR ROBERT DEBRE
30900 NIMES
France

Participants

INSERM - TRANSFERT SA
France

EU contribution: EUR 450 000


Rue Watt 7
75013 PARIS
France
ICON CLINICAL RESEARCH LIMITED
Ireland

EU contribution: EUR 698 821


SOUTH COUNTY BUSINESS PARK, LEOPARDSTOWN
18 DUBLIN
Ireland
ASSOCIATION GENETHON
France

EU contribution: EUR 272 215


RUE DE L INTERNATIONALE 1 BIS
91002 EVRY
France
HUMANITAS MIRASOLE SPA
Italy

EU contribution: EUR 450 000


Via Manzoni, 56
20089 ROZZANO-MILAN
Italy
GOETEBORGS UNIVERSITET
Sweden

EU contribution: EUR 140 500


VASAPARKEN
405 30 GOETEBORG
Sweden
UNIVERSITY OF SUSSEX
United Kingdom

EU contribution: EUR 1 237 191,25


Sussex House
BN1 9RH FALMER, BRIGHTON
United Kingdom
THE UNIVERSITY OF SHEFFIELD
United Kingdom

EU contribution: EUR 435 306


FIRTH COURT WESTERN BANK
S10 2TN SHEFFIELD
United Kingdom
KING'S COLLEGE LONDON
United Kingdom

EU contribution: EUR 490 790


Strand
WC2R 2LS LONDON
United Kingdom
QUEEN MARY UNIVERSITY OF LONDON
United Kingdom

EU contribution: EUR 159 138,75


327 MILE END ROAD
E1 4NS LONDON
United Kingdom
MOTOR NEURONE DISEASE ASSOCIATION
United Kingdom

EU contribution: EUR 0


10 15 NOTRE DAME MEWS
NN1 2BG NORTHAMPTON
United Kingdom
Record Number: 193232 / Last updated on: 2016-07-08